Abstract
Epidemiological studies on multiple sclerosis (MS) carried out in Southern Europe in the last years have shown a significant increase in the disease frequency. Previous surveys conducted in the Republic of San Marino, Northern Italian peninsula, identified that the population is at high risk for MS, with a prevalence of 51.6 per 100,000 population in 1982 and of 166.7 in 2005 and with a mean annual incidence of 7.9 per 100,000 for the period 1990–2005. The present work is a community-based intensive prevalence and incidence survey, by a complete enumeration approach, to update the prevalence and incidence of MS in the Republic of San Marino. The mean annual incidence for the period 2005–14 was 7.7 (95% CI 4.9–11.4) per 100,000, 3.3 (95% CI 1.1–7.6) for men and 11.9 (95% CI 7.2–18.6) for women. On 31 December 2014, 67 patients (19 men and 48 women), suffering from definite or probable MS and living in the Republic of San Marino, yielded a crude prevalence of 204.3 (95% CI 158.4–259.5) per 100,000, 117.8 (95% CI 70.9–183.7) for men and 288.2 (95% CI 212.4–383.3) for women. Our study has confirmed San Marino is an area at high risk for MS, in line with epidemiological data from continental Italy. The marked increase in MS prevalence over time in this population can be ascribable to increased survival and improved ascertainment, in the presence of a substantially stable, yet high, incidence rate.
Similar content being viewed by others
References
Pugliatti M, Sotgiu S, Solinas G, Castiglia P, Pirastru MI, Murgia B, Mannu L, Sanna G, Rosati G (2001) Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk. Acta Neurol Scand 103:20–26
Kurtzke JF (2005) Epidemiology and etiology of multiple sclerosis. Phys Med Rehabit Clin N Am 16:327–349
Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J, Vecsei L, Milanov I (2006) The epidemiology of multiple sclerosis in Europe. Eur J Neurol 13:700–722
Granieri E, Economou NT, De Gennaro R et al (2007) Multiple sclerosis in the province of Ferrara: evidence of an increasing trend. J Neurol 254:1642–1648
Benito-Leon J (2011) Multiple sclerosis: is prevalence rising and if so why? Neuroepidemiology 37:236–237
Nicoletti A, Patti F, Lo Fermo S, Messina S, Bruno E, Quattrocchi G, Laisa P, Cilia S, Mostile G, Marziolo R, Scillieri R, Maimone D, Zappia M (2011) Increasing frequency of multiple sclerosis in Catania, Sicily: a 30-year survey. Mult Scler 17:273–280
Kingwell E, Marriott JJ, Jetté N, Pringsheim T, Makhani N, Morrow SA, Fisk JD, Evans C, Béland SG, Kulaga S, Dykeman J, Wolfson C, Koch MW, Marrie RA (2013) Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurol 13:128
Kurtzke JF (1980) The geographical distribution of multiple sclerosis—an update with special reference to Europe and the Mediterranean region. Acta Neurol Scand 62:65–80
Granieri E, Casetta I, Tola MR (1995) Epidemiology of multiple sclerosis in Italy and in southern Europe. Acta Neurol Scand 161:60–70
Trojano M, Lucchese G, Graziano G, Taylor BV, Simpson S, Lepore V, Grand’Maison F, Duquette P, Izquierdo G, Grammond P, Amato MP, Bergamaschi R, Giuliani G, Boz C, Hupperts R, van Pesch V, Lechner-Scott J, Cristiano E, Fiol M, Oreja-Guevara C, Saladino ML, Verheul F, Slee M, Paolicelli D, Tortorella C, D’Onghia M, Iaffaldano P, Direnzo V, Butzkueven H, MSBase Study Group and the New Zealand MS Prevalence Study Group (2012) Geographical variations in sex ratio trends over time in multiple sclerosis. PLoS One 7:e48078
Granieri E, Rosati G, Tola R, Pinna L, Carreras M, Manca M, Boldrini P (1983) The frequency of multiple sclerosis in Mediterranean Europe. An incidence and prevalence study in Barbagia, Sardinia, insular Italy. Acta Neurol Scand 68:84–89
Granieri E, Casetta I, Govoni V, Tola MR, Marchi D, Murgia SB, Ticca A, Pugliatti M, Murgia B, Rosati G (2000) The increasing incidence and prevalence of MS in a Sardinian province. Neurology 55:842–848
Savettieri G, Salemi G, Ragonese P, Aridon P, Scola G, Randisi G (1998) Prevalence and incidence of multiple sclerosis in the city of Monreale, Italy. J Neurol 245:40–43
Grimaldi LM, Palmeri B, Salemi G, Giglia G, D’Amelio M, Grimaldi R, Vitello G, Ragonese P, Savettieri G High prevalence and fast rising incidence of multiple sclerosis in Caltanissetta, Sicily, southern Italy(2007) Neuroepidemiology 28:28–32
Morganti G, Naccarato S, Ellan M et al (1984) Multiple sclerosis in the Republic of San Marino. J Epidemiol Community Health 38:23–28
Granieri E, Monaldini C, De Gennaro R et al (2007) Multiple sclerosis in the Republic of San Marino: a prevalence and incidence study. Mult Scler 00:1–5
Statistics Office of the Republic of San Marino (2015) Demographic balance (movement of the resident population), www.statistica.sm/on-line/en/home/statistics/docCat.14000847.1.10.1.html. Accessed 30 Sept 2015
Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452
Italian National Institute of Statistics (2011) Population Census. http://dati-censimentopopolazione.istat.it/Index.aspx?lang=en. 2012, Accessed 30 Sept 2015
Waterhouse JAH, Muir CS, Correa P et al (eds) (1976) Cancer incidence in five continents, vol 3. IARC, Lyon, p 456
Schoenberg BS (1983) Calculating confidence intervals for rates and ratios: simplified methods utilizing tabular values based in the Poisson distribution. Neuroepidemiology 2:257–265
Armitage P (1995) Tests for linear trends in proportions and frequencies. Biometrics 11:375–386
Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46:907–911
Ranzato F, Perini P, Tzintzeva E, Tiberio M, Calabrese M, Ermani M, Davetag F, de Zanche L, Garbin E, Verdelli F, Villacara A, Volpe G, Moretto G, Gallo P (2003) Increasing frequency of multiple sclerosis in Padova, Italy: a 30 year epidemiological survey. Mult Scler 9:387–392
Forbes RB, Wilson SV, Swingler RJ (1999) The prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist? J Neurol 246:1033–1040
Handel AM, McLaughlin R, Fries A et al (2011) The epidemiology of multiple sclerosis in Scotland: inferences from hospital admissions. PLoS One 6:e14606
McDonnell GV, Hawkins SA (1998) An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology 50:423–428
Grytten N, Aarseth JH, Lunde HMB et al (2015) A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway. J Neurol Neurosurg Psychiatry 0:1–6
Govoni V, Casetta I, Granieri E, Vernonesi V, Malagù S, Tola MR, Paolino E, Fainardi E, Monetti VC, Aiello I (1993) Mortality study on multiple sclerosis in the province of Ferrara, northern Italy, 1968 through 1989. Acta Neurol 15:161–176
Benedikz J, Magnésson H, Guòmundsson G (1994) Multiple sclerosis in Iceland, with observations on the alleged epidemic in the Faroe Islands. Ann Neurol 36:S175–S179
Kramer MA, Van der Maas NAT, Van Soest EM et al (2012) Incidence of multiple sclerosis in the general population in the Netherlands, 1996–2008. Neuroepidemiology 39:96–102
Alonso A, Hernán M (2008) Temporal trend in the incidence of multiple sclerosis. Neurology 71:129–135
Casetta I, Granieri E (2000) Clinical infections and multiple sclerosis: contribution from analytical epidemiology. J Neuro-Oncol 6:S147–S151
Pugliatti M, Riise T, Sotgiu A et al (2006) Evidence of early childhood as the susceptibility period in multiple sclerosis: space-time cluster analysis in a Sardinian population. Am J Epidemiol 164:326–333
Ascherio A, Munger KL (2010) 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence. Clin Exp Immunol 160:120–124
Simon KC, Van der Mei I, Munger KL et al (2010) Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology 74:1365–1371
Acknowledgements
The authors thank Eva Sjolin for her help in revising the translation of the text.
Funding
This work is supported by Ferrara University (Fondo di Ateneo per la Ricerca).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval
Ethics approval for the study was obtained.
Rights and permissions
About this article
Cite this article
Caniglia-Tenaglia, M., Guttmann, S., Monaldini, C. et al. Multiple sclerosis in the Republic of San Marino, Italian peninsula: an incidence and prevalence study from a high-risk area. Neurol Sci 39, 1231–1236 (2018). https://doi.org/10.1007/s10072-018-3402-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-018-3402-6